Tenders/Procurement of Rivaroxaban and Denosumab medicinal products for the period 1.9.2026-31.12.2027
Awarded🇫🇮FinlandSupplies

Procurement of Rivaroxaban and Denosumab medicinal products for the period 1.9.2026-31.12.2027

Auto-translated from fi
Original title: Rivaroksabaani- ja denosumabilääkevalmisteiden hankinta kaudelle 1.9.2026-31.12.2027
Pirkanmaan hyvinvointialue
Published: Sep 20, 2026
Updated: Sep 23, 2026
Source: Hilma Finland

About This Opportunity

This is a supplies contract in the health and medical services and trade and industry sectors, with a focus on Retail. Located in Finland, Europe, this opportunity is open to firms and consortiums.

Published through Hilma Finland, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from fi
The subject of the procurement were rivaroxaban capsules and tablets 10 mg, 15 mg, and 20 mg (ATC: B01AF01) and denosumab injections (ATC: M05BX04) with marketing authorization in Finland. Partial bids were considered on a product-by-product basis, allowing the tenderer to participate in the tender by offering one or more products for either one or both lots. A more detailed description of the procurement is provided in the tender documents. The procurement ring includes the wellbeing services counties of Pirkanmaa, South Ostrobothnia, and Kanta-Häme. The joint procurement is carried out on behalf of the wellbeing services counties of Pirkanmaa, South Ostrobothnia, and Kanta-Häme by the hospital pharmacy of the Pirkanmaa wellbeing services county. Lot 1: Rivaroxaban capsules and tablets 10 mg, 15 mg, and 20 mg The subject of the procurement were rivaroxaban capsules and tablets 10 mg, 15 mg, and 20 mg (ATC: B01AF01) with marketing authorization in Finland. Partial bids were considered on a product-by-product basis, allowing the tenderer to participate in the tender by offering one or more products. A more detailed description of the procurement is provided in the tender documents. Lot 2: Denosumab injections The subject of the procurement were denosumab injections (ATC: M05BX04) with marketing authorization in Finland. Partial bids were considered on a product-by-product basis, allowing the tenderer to participate in the tender by offering one or more products. A more detailed description of the procurement is provided in the tender documents.

Data provenance

This notice is sourced from Hilma Finland and was originally published on September 20, 2026. Last refreshed 55 days ago. Original language: fi. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Pirkanmaan hyvinvointialue

Pirkanmaan hyvinvointialue has issued 206 procurement notices on BidsFactory, including 35 currently open and 72 awarded contracts. Activity concentrates in Health & Medical, Construction & Civil Works, and Architecture & Engineering Services. All notices are published for Finland. Notices are distributed via Hilma Finland and TED - Tenders Electronic Daily (EU). Most recent publication: November 17, 2026.

Pirkanmaan hyvinvointialue: buyer profile, tenders and awards

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Finland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Hilma Finland to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to Accord Healthcare Oy (2425744-1)//Avansor Pharma Oy (1835834-2)//Celltrion Healthcare Finland Oy (2996306-2)//Orion Oyj (1999212-6). The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Pirkanmaan hyvinvointialue in Finland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Key Details

Submission Deadline
Mar 20, 2027
122 days remaining
Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
fi

Source

hilma_fi
Hilma Finland
Public Procurement

Contracting Authority

Pirkanmaan hyvinvointialue
🇫🇮Finland